Update: YMC Process Technologies is now under the brand YMC America
Zurich, Switzerland – August 15, 2018. ChromaCon AG, a specialist in laboratory-scale continuous and batch chromatography solutions for biopharmaceutical process development, confirms the continuity and expansion of its long-standing collaboration following the acquisition of LEWA’s bioprocessing division by YMC Co., Ltd.
ChromaCon strengthens continuous chromatography partnership with YMC Process Technologies after LEWA acquisition
LEWA-Nikkiso America Inc. and YMC Co., Ltd. have announced that LEWA’s bioprocessing division will be acquired by YMC, forming a new entity, YMC Process Technologies headquartered in Devens, MA, USA. This acquisition brings together LEWA’s expertise in bioprocessing hardware with YMC’s leadership in chromatography media and systems to better serve the biopharmaceutical market with scalable, GMP-ready purification solutions.
A joint press release by LEWA and YMC announcing the transaction and addressing key questions about the integration has been published and is available from the companies.
Commitment to customers: seamless transition and expanded capabilities
Dr. Michael Bavand, CEO of ChromaCon AG, emphasized the company’s commitment to its existing and future customers as responsibilities transition from LEWA to YMC Process Technologies.
“We want to assure our customers that a seamless transfer in our business relationship between LEWA and YMC is warranted,” said Dr. Bavand. “We have worked closely with LEWA to co-develop and co-market a leading continuous chromatography scale-up system based on our proprietary twin-column technology. YMC has been a valued business partner for many years as our distributor in Japan and India. We look forward to continuing and expanding our collaboration with YMC Process Technologies into additional, significant business areas.”
With this strengthened partnership, biopharmaceutical developers benefit from:
- End-to-end solutions from laboratory-scale method development to GMP pilot and production scale
- Proven twin-column continuous chromatography technology for higher productivity and improved resin utilization
- Global support through YMC’s and LEWA’s established sales and service networks
Proven twin-column technology and industry recognition
The collaboration between ChromaCon, LEWA and YMC is built on a track record of innovation in continuous chromatography and downstream processing.
LEWA’s EcoPrime Twin system, implementing ChromaCon’s twin-column process technology, received the Aspen Award for the Advancement of Downstream Processing in 2017, recognizing its contribution to efficient and scalable biopharmaceutical purification.
Earlier in 2018, a major milestone was achieved with the successful scale-up of ChromaCon’s proprietary CaptureSMB process by Bristol-Myers Squibb. The work, published in Bioprocessing International, demonstrated robust and economical twin-column Protein A capture at larger scale, confirming the industrial relevance of ChromaCon’s technologies for monoclonal antibody purification.
Together, ChromaCon, LEWA and YMC Process Technologies provide a strong platform for companies seeking to implement continuous chromatography, improve resin utilization and reduce CAPEX and OPEX in downstream bioprocessing.
About ChromaCon AG
ChromaCon AG is a private life science tools company headquartered in Zürich, Switzerland, providing best-in-class laboratory-scale chromatography equipment, software and process solutions to the biopharmaceutical industry.
The company has developed and patented novel process principles, process control and simulation software, equipment designs and operating software for batch, cyclic and continuous chromatography. These solutions enable scalable chromatographic purification with significant capital and operating cost savings across a wide range of biologics and high-value molecules.
ChromaCon’s Contichrom® laboratory-scale equipment is co-marketed worldwide together with selected partners. ChromaCon has also granted global licenses for its process technologies to YMC Process Technologies (Devens, MA, USA) for implementation in scale-up and GMP manufacturing systems.
ChromaCon Contact
To find out more about ChromaCon’s chromatography solutions, please contact:
Dr. Thomas Müller-Spaeth, CEO
www.chromacon.com
About YMC Process Technologies
YMC Process Technologies creates advanced downstream bio/pharmaceutical processing platforms. Their systems are designed to deliver the work of multiple competitive units in a smaller footprint, supporting efficient and flexible manufacturing strategies.
Leveraging deep expertise in fluid dynamics and industry-leading pump technology, LEWA provides precise batch-to-continuous processing solutions with an optimal balance of accuracy, repeatability and precision. Integrated design, fabrication and automation services deliver single-point, vertically integrated supply, helping customers accelerate time to operation.
Contact YMC Process Technologies
To find out more about LEWA’s bioprocessing platforms, please contact:
sales@ymcamerica
www.ymcamerica.com
About YMC Co., Ltd.
YMC Co., Ltd., founded in 1980 in Kyoto, Japan, is a global manufacturer of HPLC and preparative chromatography products. From its inception, YMC has focused on developing high-performance columns and packing materials that meet the demanding requirements of analytical and preparative separation.
As a pioneer in industrial chromatography, YMC has developed complete systems for large-scale preparative purification and provides separation and purification technologies for high value-added substances, including active pharmaceutical ingredients (APIs). By combining expertise in both packing media and chromatography systems, YMC has built a new GMP-compliant purification plant and actively offers contract purification services, with a focus on APIs and other high-value biopharmaceutical products.
YMC Contact
To find out more about YMC and YMC Process Technologies, please contact:
Mr. Yoshihisa Ohyagi, Director
www.ymc.co.jp
